Shoreline Biosciences, Inc., a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune ...

Stifel has downgraded Tempus AI (NASDAQ:TEM) to hold from buy, citing valuation and uncertainty about core growth in 2025.

Comedians Patton Oswalt and Tig Notaro co-headline a show at Stifel Theater for St. Louis' Flyover Comedy Festival on Nov. 15 ...

Crossmark Global Holdings Inc. raised its holdings in Stifel Financial Corp. (NYSE:SF – Free Report) by 12.8% in the third ...

With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...

Fintel reports that on November 15, 2024, Stifel initiated coverage of EMCOR Group (NYSE:EME) with a Buy recommendation.

Stifel Nicolaus analyst Jeffrey Stantial reiterated a Buy rating on Gambling.com (GAMB – Research Report) today and set a price target of ...

In a report released today, Brad Reback from Stifel Nicolaus maintained a Buy rating on Elastic (ESTC – Research Report), with a price ...

We recently compiled a list of the 15 AI News You Missed This Week. In this article, we are going to take a look at where ...

U.S. Ski and Snowboard made the announcement Thursday morning that Vonn will rejoin the team for the 2024-25 season.

Investors interested in arranging a one-on-one meeting during the conference should contact their Stifel representative.

today announced that members of management will present at the 2024 Stifel Healthcare conference on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time. A live and archived webcast of the ...